Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05079334 · ClinicalTrials.gov registry record

Family History and Cancer Risk Study

A clinical trial of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research, sponsored by Vanderbilt University Medical Center.

Active
Registry status
1,847
Enrollment target
2
Study locations

NCT05079334 is a study of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research that is active but no longer recruiting, run by Vanderbilt University Medical Center. The registered enrollment target is 1,847 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05079334, a study of Neoplastic Syndromes, Hereditary and Comparative Effectiveness Research, is active but no longer recruiting, sponsored by Vanderbilt University Medical Center.

ACTIVE NOT RECRUITING
Registry status
1,847 participants
Enrollment target
2
Study locations

Study Summary

Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and MeTree will determine the participant's cancer risk based on current guidelines. The study team will offer genetic counseling to high-risk participants. Investigators will track participant outcomes and behaviors from the use of MeTree to determine the efficiency of the use of MeTree compared to completion of pedigrees in clinic.

Study Locations (2)

Tennessee

  • Meharry Medical College - Nashville
  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 1,847 participants
Start Date 2022-01-01
Est. Completion 2026-06

What the Registry Record Tells You About NCT05079334

The ClinicalTrials.gov registry entry for NCT05079334 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,847 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Neoplastic Syndromes, Hereditary appearing as the primary indexed condition, and to 0 interventions.

NCT05079334 reports 2 study locations spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT05079334 about?

NCT05079334 is a clinical study titled "Family History and Cancer Risk Study". Investigators from Vanderbilt University Medical Center (VUMC), Duke University, and Meharry Medical College (MMC) are collaborating on a family health history study to deploy a family health history (FHH) platform, MeTree. Recruited participants will complete surveys, the MeTree questionnaire, and ...

What is the current status of trial NCT05079334?

This trial is currently active not recruiting. The enrollment target is 1,847 participants. The study started on 2022-01-01. Estimated completion is 2026-06.

What conditions does trial NCT05079334 study?

This clinical trial studies the following conditions: Neoplastic Syndromes, Hereditary, Comparative Effectiveness Research.

Who is sponsoring clinical trial NCT05079334?

This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05079334 being conducted?

This trial has 2 study locations across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.